IL1B rs1143634: Dietary Fatty Acids and Inflammation
The rs1143634 variant is a well-studied single nucleotide polymorphism located in the IL1B gene, which encodes the key pro-inflammatory cytokine interleukin-1 beta. Research in nutrigenomics associates this variant with variations in systemic inflammatory markers and differential responses to dietary omega-3 polyunsaturated fatty acids. However, clinical evidence remains limited and observational, serving as an indicator of biological variation rather than a definitive diagnosis of disease.
What each genotype means
Higher inflammatory cytokine potential
Research indicates that individuals with the CC genotype may exhibit higher plasma concentrations of interleukin-1 beta compared to those carrying the T allele. This variant is sometimes referred to in literature as +3954 C/T, and associations with inflammatory markers or clinical outcomes like cachexia remain a subject of ongoing study. Please discuss any concerns regarding systemic inflammation or health management with your clinician.
This is a common genotype, though exact frequencies vary significantly by global ancestry.
Intermediate inflammatory marker profile
As a carrier of both the C and T alleles, your profile represents an intermediate state regarding the potential modulation of interleukin-1 beta production. This variant, often noted as +3954 C/T, has been investigated for its role in how the body responds to inflammatory triggers and dietary factors. Because the evidence is limited and often context-dependent, please consult with a healthcare professional to interpret these findings in the context of your overall health.
This heterozygous genotype is frequently observed across diverse populations, often representing a significant portion of the population.
Lower inflammatory cytokine potential
The TT genotype is associated with different levels of interleukin-1 beta expression compared to the CC genotype in some research settings. Often documented as the +3954 T allele, this variant is studied for its potential influence on inflammatory responses and sensitivity to dietary omega-3 fatty acids. As these associations are complex and not diagnostic, please discuss your health goals and any inflammatory concerns with your doctor or a registered dietitian.
This genotype is present in a substantial minority of the population, with frequencies varying by ethnic background.
Genetic Location and Molecular Characteristics
The single nucleotide polymorphism rs1143634 is situated on chromosome 2 within exon 5 of the IL1B gene, historically cataloged in scientific literature as +3954 C>T (or +3953 depending on numbering conventions). At this specific genomic position, the major allele is cytosine (C), while the minor alternative allele is thymine (T). In various literature reports, strand annotations may present this substitution as guanine (G) to adenine (A). Because it resides within an exonic region of the gene, researchers have extensively studied rs1143634 to evaluate whether the nucleotide change influences messenger RNA stability, translation efficiency, or secretion levels of the interleukin-1 beta protein. Rather than causing monogenic disease, rs1143634 acts as a common regulatory polymorphism that subtly modulates baseline physiological states across human populations.
The Biological Role of the IL1B Gene
The IL1B gene provides the genetic blueprint for producing interleukin-1 beta (IL-1β), an essential pro-inflammatory cytokine primarily produced by monocytes, tissue macrophages, and dendritic cells. Interleukin-1 beta acts as a potent molecular alarm signal during immune defense, triggering local vascular changes, leukocyte recruitment, fever induction, and the synthesis of downstream acute-phase reactants such as C-reactive protein (CRP) and interleukin-6. While robust IL-1β signaling is crucial for clearing infectious pathogens and initiating tissue repair, chronic dysregulation or persistent low-grade overproduction has been implicated in long-term metabolic disruption, adipose tissue inflammation, insulin resistance, and atherogenesis. Consequently, genetic differences that modulate IL1B transcription or cytokine release can tilt the balance between acute protective immunity and chronic inflammatory signaling.
Nutrigenomic Interactions and Inflammatory Markers
In nutrigenomics, rs1143634 has drawn significant interest due to gene-diet interaction studies investigating lipid metabolism and inflammatory profiles. Observational research indicates that individuals carrying the minor T (or A) allele may display altered baseline cytokine production and differential sensitivity to dietary anti-inflammatory fats, notably long-chain omega-3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA). In some cohort studies, the anti-inflammatory efficacy of dietary omega-3 intake in reducing markers of metabolic syndrome or inflammatory cytokines varied depending on rs1143634 genotype. However, overall scientific evidence remains categorized as limited. Findings across distinct cohorts have occasionally produced mixed results, with some cohorts observing protective effects and others finding altered susceptibility to inflammatory conditions or elevated baseline markers. As a result, rs1143634 cannot be considered an independent diagnostic or prognostic marker on its own.
Population Distribution and Ancestral Patterns
The minor allele of rs1143634 exhibits substantial frequency differences across global populations. In European cohorts, the minor allele frequency typically falls between 20% and 30%, making heterozygous carriers common in populations of European ancestry. In contrast, East Asian and African populations demonstrate noticeably lower frequencies of the alternative allele, often dropping below 5% to 10% in certain sub-cohorts. Such pronounced ancestral divergence underscores why genetic association findings often fail to replicate across ethnically diverse populations. When evaluating genetic risk or nutritional interactions involving rs1143634, individual ancestral background must be accounted for to prevent inaccurate inferences regarding baseline inflammatory susceptibility.
Clinical Realities: What You Can and Cannot Do
Knowing your rs1143634 genotype offers educational context into baseline inflammatory pathways, but it cannot diagnose chronic illness, autoimmune disorders, or metabolic conditions. A genetic tendency toward altered cytokine production is only one small component of overall immune function, interacting dynamically with lifestyle factors, physical activity, sleep quality, gut microbiota, and overall nutritional balance. You should not begin high-dose dietary supplements, alter cardiovascular medication, or modify medical treatment based solely on this genotype. If you are exploring dietary changes—such as increasing intake of fatty fish, walnuts, or omega-3 fatty acids—or if you have questions regarding medication and systemic inflammation, discuss these strategies directly with a registered dietitian, physician, or qualified healthcare professional.
How common is this variant?
The minor allele frequency for rs1143634 generally ranges between 20% and 35% across European and American populations, while appearing at significantly lower frequencies (often under 5% to 10%) in East Asian populations.
Frequently asked questions
What is the biological role of the IL1B rs1143634 variant?
The rs1143634 variant is a single nucleotide substitution in the IL1B gene, which encodes the pro-inflammatory signaling molecule interleukin-1 beta. It has been evaluated in research studies for its ability to subtly modulate cytokine secretion and cellular inflammatory activity.
Does having the rs1143634 minor allele mean I have chronic inflammation?
No. Genetic variants confer statistical propensities rather than clinical diagnoses. Daily habits such as physical activity, sleep, stress management, and overall dietary quality exert far greater influence on systemic inflammation than any individual genetic variant.
Should I take omega-3 fish oil supplements if I carry rs1143634?
Nutrigenomic studies suggest that dietary omega-3 fatty acids interact with inflammatory genotypes, but evidence is too preliminary to prescribe personalized supplementation protocols. You should speak with a healthcare provider or dietitian before starting high-dose dietary supplements.
Why is the evidence for rs1143634 rated as limited?
While many published studies examine rs1143634, findings across diverse cohorts are often heterogeneous or contradictory. Many associations stem from small, observational studies that demonstrate correlation rather than direct causation, preventing firm clinical conclusions.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1143634?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL1B
This SNP is recognized as a modifier of inflammatory response, potentially affecting responses to anti-TNF therapies.
Promoter single nucleotide polymorphism influencing baseline inducible interleukin-1 beta transcriptional activity and inflammatory response phenotypes.
Promoter variant (c.-511C>T) in the IL1B gene extensively studied for regulatory influence on interleukin-1 beta expression and chronic inflammatory states.
Promoter regulatory single-nucleotide variant in interleukin-1 beta associated with altered inflammatory cytokine secretion and chronic inflammation predisposition.
This variant is associated with altered cytokine production and susceptibility to inflammatory conditions.
This polymorphism in the interleukin-1 beta gene has been studied for its role in the pharmacogenomics of apremilast response in patients with psoriasis.